Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Optical Transillumination Spectroscopy of Breast Tissue for Cancer Risk Assessment.

Not Accessible

Your library or personal account may give you access

Abstract

Breast cancer is the most commonly occurring cancer in women. The lifetime risk of being diagnosed with breast cancer is approximately 1 in 10 thereby the highest out of all cancers. Breast cancer screening programs have been shown to decrease the mortality rates of women between ages 50–69, since cancers are detected at an earlier, more favourable stage. It is apparent that the development of breast cancer is a slow process following initial transformation of the breast tissue. Hence, there has been a strong effort within the research community to understand risk factors for the disease. Risk factors are defined as those characteristics that are more common in people with the disease when compared to the normal population. Quantification of an individual’s breast cancer risk may lead that individual to modify her lifestyle and/or diet. Lifestyle changes could lead to a reduction in the incidence of breast cancer.

Anatomically, the presence of increased amounts of fibroglandular tissue raises the estimated risk by up to 6 fold (corrected for age), hence representing one of the strongest known risk factors pertaining to the entire female population. In this study the relative area of mammographic densities within a mammogram will be used as a global risk assessment tool. It has been shown previously that quantification of water, lipids, haemoglobin and other tissue chromophores of the optically interrogated breast tissue, which also gives rise to the mammographic densities, is feasible through nearinfrared spectroscopy. Thus, the hypothesis for this study is that optical transillumination spectroscopy provides consistent and/or complementary information to conventional mammography in quantifying breast tissue density.

© 2003 SPIE

PDF Article
More Like This
Optical transillumination spectroscopy: a biomarker of breast tissue density and an intermediate indicator of cancer risk

K. M. Blackmore, L. Lilge, J. A. Knight, and R. Jong
TuH16 European Conference on Biomedical Optics (ECBO) 2005

Characterization of breast tissue composition and breast cancer risk assessment using non-invasive Transillumination Breast Spectroscopy (TIBS)

R.A. Weersink, K. M. Blackmore, S. Dick, B.C. Wilson, M. Nielsen, and L. Lilge
ME69 Biomedical Topical Meeting (BIOMED) 2006

Transillumination Breast Spectroscopy (TiBS): Near-infrared optical spectroscopy to monitor bulk tissue changes for breast cancer risk reducing interventions.

Samantha Dick, Kristina Blackmore, Ellen Greenblatt, and Lothar Lilge
BSuE70 Biomedical Optics (BIOMED) 2008

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All Rights Reserved